Pharmaceutical Benefits Scheme updates to start 2020 The safety net threshold has been lowered, while a new drug that provides a treatment option for patients with advanced breast cancer has been added.
GP poll: Iron infusions in general practice Would appropriate remuneration encourage you to offer this service more often?
Australian GP named in global list of elite researchers Professor Paul Glasziou has been recognised as one of the world’s most cited researchers in 2019.
People experiencing psoriasis and asthma receive PBS relief Patients with urea cycle disorder will also benefit from the new round of listings.
Australian drug prices low by world standards A new report has found Australians are paying among the lowest prices in the world for generic prescription drugs.
Cystic fibrosis drug listed on PBS While the announcement was welcomed, some have questioned the seven month delay between approval and listing.
Pharmaceutical Benefits Advisory Council responds to criticism Chair Andrew Wilson said suggestions of delayed approvals are not new and Australia has one of ‘the fastest systems in the world’.
Cancer and inflammatory disease medicines receive $56 million boost Four new medicines will be listed through the Pharmaceutical Benefits Scheme, helping patients fight aggressive cancers and inflammatory conditions.
Access to cystic fibrosis medication expanded Children aged 12–24 months with a rare form of the genetic disorder will soon be eligible to receive subsidised medication, saving their families up to $300,000 per year.
Behind the scenes at the PBAC Outgoing RACGP representative Rashmi Sharma pulls back the curtain after 10 years on the Pharmaceutical Benefits Advisory Committee.